Researchers at Brigham and Women’s Hospital have developed a nasal spray that could provide broad-spectrum protection against ...

Recently in 2024, the agency received a report involving a patient who received the nasal solution as an injection.

Iconovo AB, a developer of inhalable drugs based on proprietary inhalers and dry powder formulations, and Lonza, a healthcare ...

Hikma Pharmaceuticals PLC, the multinational pharmaceutical group, has entered an exclusive commercial partnership with ...